CA Stock MarketDetailed Quotes

TTI Thiogenesis Therapeutics Corp

Watchlist
  • 0.680
  • 0.0000.00%
15min DelayMarket Closed Sep 27 16:00 ET
30.94MMarket Cap-6181P/E (TTM)

Thiogenesis Therapeutics Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
-594.05K
Net income from continuing operations
25.17%-651.32K
33.38%-710.57K
-29.02%-5.06M
-365.12%-2.07M
-49.42%-1.05M
-75.08%-870.39K
53.13%-1.07M
-222.12%-3.92M
-31.95%-445.34K
---705.78K
Operating gains losses
----
----
----
----
----
----
----
11.94%-56.19K
-242.30%-125.67K
--0
Remuneration paid in stock
-45.46%66.21K
-53.90%80.37K
-8.29%480.91K
-59.97%94.53K
-9.69%90.64K
26.19%121.39K
90.18%174.36K
7,183.87%524.37K
10,347.88%236.12K
--100.37K
Other non cashItems
----
----
----
----
----
----
----
--1.94M
--77.77K
---1
Change In working capital
-46.75%34K
-8,013.00%-1.37M
334.46%1.33M
5,114.12%1.28M
-343.98%-27.73K
108.19%63.85K
-92.34%17.26K
-212.25%-568.81K
-111.06%-25.53K
--11.37K
-Change in receivables
270.53%48.06K
-127.84%-10.31K
-126.07%-29.33K
-25.26%-40.02K
4,417.07%1.85K
-51.76%-28.18K
-77.28%37.03K
167.32%112.48K
-154.89%-31.95K
--41
-Change in prepaid assets
10,943.00%22.09K
-56.48%12.79K
-10.69%-42.75K
-86.80%-72.15K
---191
--200
--29.39K
-221.34%-38.62K
---38.62K
--0
-Change in payables and accrued expense
-139.36%-36.15K
-2,683.69%-1.37M
318.73%1.41M
2,991.39%1.39M
-359.53%-29.39K
112.06%91.84K
-178.96%-49.15K
-200.10%-642.66K
-68.02%45.04K
--11.33K
Cash from discontinued investing activities
Operating cash flow
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
---594.05K
Investing cash flow
Cash flow from continuing investing activities
0
0
107.46K
-3.24M
0
Net business purchase and sale
----
----
--0
--0
----
----
----
--107.46K
---3.24M
--0
Cash from discontinued investing activities
Investing cash flow
----
----
--0
--0
----
----
----
--107.46K
---3.24M
--0
Financing cash flow
Cash flow from continuing financing activities
0
462.5K
-49.29%4.12M
-49.80%4.12M
0
0
0
892.85%8.13M
5,475.92%8.21M
3.68K
Net issuance payments of debt
----
----
--0
--0
----
----
----
-221.90%-175.17K
-82.60%25K
--0
Net common stock issuance
----
----
-15.55%4.12M
----
----
----
----
623.16%4.88M
----
----
Proceeds from stock option exercised by employees
--0
--462.5K
--0
--0
--0
--0
--0
--3.42M
--3.31M
--3.68K
Cash from discontinued financing activities
Financing cash flow
--0
--462.5K
-49.29%4.12M
-49.80%4.12M
--0
--0
--0
892.85%8.13M
5,475.92%8.21M
--3.68K
Net cash flow
Beginning cash position
3.86%5.52M
14.21%7.08M
9,805.77%6.2M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,951.69%6.2M
225.98%62.55K
2,297.75%1.61M
--2.22M
Current changes in cash
19.56%-551.12K
-75.24%-1.53M
-85.80%872.76K
-26.90%3.42M
-67.97%-991.64K
45.98%-685.15K
-126.37%-875.06K
12,094.89%6.14M
75,902.94%4.68M
---590.37K
Effect of exchange rate changes
-126.98%-2.46K
-718.32%-19.03K
169.05%7.58K
119.38%20.08K
-74.59%-19.29K
148.38%9.12K
-101.90%-2.33K
-56.36%-10.98K
-818.63%-103.58K
---11.05K
End cash Position
7.06%4.97M
3.86%5.52M
14.21%7.08M
14.21%7.08M
125.03%3.63M
109.57%4.64M
51.86%5.32M
9,805.77%6.2M
9,805.77%6.2M
--1.61M
Free cash from
19.56%-551.12K
-128.10%-2M
-55.45%-3.25M
-146.45%-696.61K
-66.93%-991.64K
41.98%-685.15K
-2,618.35%-875.06K
-172.05%-2.09M
-100.35%-282.66K
---594.05K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K-594.05K
Net income from continuing operations 25.17%-651.32K33.38%-710.57K-29.02%-5.06M-365.12%-2.07M-49.42%-1.05M-75.08%-870.39K53.13%-1.07M-222.12%-3.92M-31.95%-445.34K---705.78K
Operating gains losses ----------------------------11.94%-56.19K-242.30%-125.67K--0
Remuneration paid in stock -45.46%66.21K-53.90%80.37K-8.29%480.91K-59.97%94.53K-9.69%90.64K26.19%121.39K90.18%174.36K7,183.87%524.37K10,347.88%236.12K--100.37K
Other non cashItems ------------------------------1.94M--77.77K---1
Change In working capital -46.75%34K-8,013.00%-1.37M334.46%1.33M5,114.12%1.28M-343.98%-27.73K108.19%63.85K-92.34%17.26K-212.25%-568.81K-111.06%-25.53K--11.37K
-Change in receivables 270.53%48.06K-127.84%-10.31K-126.07%-29.33K-25.26%-40.02K4,417.07%1.85K-51.76%-28.18K-77.28%37.03K167.32%112.48K-154.89%-31.95K--41
-Change in prepaid assets 10,943.00%22.09K-56.48%12.79K-10.69%-42.75K-86.80%-72.15K---191--200--29.39K-221.34%-38.62K---38.62K--0
-Change in payables and accrued expense -139.36%-36.15K-2,683.69%-1.37M318.73%1.41M2,991.39%1.39M-359.53%-29.39K112.06%91.84K-178.96%-49.15K-200.10%-642.66K-68.02%45.04K--11.33K
Cash from discontinued investing activities
Operating cash flow 19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K---594.05K
Investing cash flow
Cash flow from continuing investing activities 00107.46K-3.24M0
Net business purchase and sale ----------0--0--------------107.46K---3.24M--0
Cash from discontinued investing activities
Investing cash flow ----------0--0--------------107.46K---3.24M--0
Financing cash flow
Cash flow from continuing financing activities 0462.5K-49.29%4.12M-49.80%4.12M000892.85%8.13M5,475.92%8.21M3.68K
Net issuance payments of debt ----------0--0-------------221.90%-175.17K-82.60%25K--0
Net common stock issuance ---------15.55%4.12M----------------623.16%4.88M--------
Proceeds from stock option exercised by employees --0--462.5K--0--0--0--0--0--3.42M--3.31M--3.68K
Cash from discontinued financing activities
Financing cash flow --0--462.5K-49.29%4.12M-49.80%4.12M--0--0--0892.85%8.13M5,475.92%8.21M--3.68K
Net cash flow
Beginning cash position 3.86%5.52M14.21%7.08M9,805.77%6.2M125.03%3.63M109.57%4.64M51.86%5.32M9,951.69%6.2M225.98%62.55K2,297.75%1.61M--2.22M
Current changes in cash 19.56%-551.12K-75.24%-1.53M-85.80%872.76K-26.90%3.42M-67.97%-991.64K45.98%-685.15K-126.37%-875.06K12,094.89%6.14M75,902.94%4.68M---590.37K
Effect of exchange rate changes -126.98%-2.46K-718.32%-19.03K169.05%7.58K119.38%20.08K-74.59%-19.29K148.38%9.12K-101.90%-2.33K-56.36%-10.98K-818.63%-103.58K---11.05K
End cash Position 7.06%4.97M3.86%5.52M14.21%7.08M14.21%7.08M125.03%3.63M109.57%4.64M51.86%5.32M9,805.77%6.2M9,805.77%6.2M--1.61M
Free cash from 19.56%-551.12K-128.10%-2M-55.45%-3.25M-146.45%-696.61K-66.93%-991.64K41.98%-685.15K-2,618.35%-875.06K-172.05%-2.09M-100.35%-282.66K---594.05K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data